Based on these findings, we showed in our previous work that in breast cancer NGAL expression is correlated with negative hormone receptor (HR) status, human epidermal growth factor receptor 2 (HER2) overexpression, poor grading and positive nodal status. This evidence concerns the gene LCN2 and breast carcinoma.